Articles by Nafees Malik - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Nafees Malik

Allogeneic Versus Autologous Stem-Cell Therapy

The author discusses potential manufacturing costs and commercialization challenges of allogeneic and autologous stem-cell therapy.
Jul 1, 2012

The author discusses potential manufacturing costs & challenges of allogeneic & autologous stem-cell therapy.

Supplementary Material for Allogeneic Versus Autologous Stem-Cell Therapy: Manufacturing Costs and Commercialization Strategies

This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."
Jul 1, 2012

This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."

Has the Era of Blockbuster Drugs Come to an End?

Personalized medicines could become more popular than top earning drugs that face patent expiry
Dec 1, 2007

Eighty drugs will lose patent protection between 2007 and 2011.

ADVERTISEMENT

ADVERTISEMENT

Click here